71PD REVERSIBLE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASES INIHIBITORS (REGFR-TKIS), ERLOTINIB OR GEFITINIB, COMPARED TO CHEMOTHERAPY (CHT) IN PREVIOUSLY TREATED METASTATIC NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS): A META-ANALYSIS

✍ Scribed by Pochesci, A.; Trenta, P.; Iacovelli, R.; Palleschi, M.; Prete, A.A.; Magri, V.; Mosillo, C.; Pellegrino, D.; De Benedetto, A.; Cortesi, E.

• Book ID: 122779943
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 57 KB
• Volume: 80
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(13)70291-5